Gilead weekly oral hold should not affect lenacapavir PDUFA, says RBC Capital

What caused the massive Google Cloud outage today? Why is Warner Bros. splitting up its media empire? How will BlackRock’s new targets affect asset management? What impact did the Air India Boeing 787 crash have? Why is Frito-Lay shutting down its Southern California plant? How are GOP plans affecting green energy tax credits? What caused the late dip in Bitcoin and crypto prices?

Gilead weekly oral hold should not affect lenacapavir PDUFA, says RBC Capital

finance.yahoo.com/news/gilead-weekly-oral-hold-not-142013995.html

In This Article:
RBC Capital notes that Gilead (GILD) shared a statement that its weekly oral HIV treatment program 1720/4182 combo has been placed on a clinical hold following decreases in CD4 and lymphocyte counts observed in subset of patients. The firm’s view had been that ‘1720 had…

This story appeared on finance.yahoo.com, 2025-06-11 14:20:13.